Bladder Cancer - Results from #140

Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease. February 19, 2025

News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC Solution Available in Countries Where System Blue and Richard Wolf Reusable Flexible Cystoscopes Are Cleared February 18, 2025

The oncological impact of complete transurethral resection before neoadjuvant chemotherapy in muscle-invasive bladder cancer. February 18, 2025

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure. February 18, 2025

Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. February 16, 2025

Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review. February 16, 2025

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes. February 14, 2025

Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma wor February 14, 2025

Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study. February 13, 2025

Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy. February 13, 2025

Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs. February 12, 2025

Gemcitabine versus Bacillus Calmette-Guerin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer. February 12, 2025

Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma. February 11, 2025

Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies. February 11, 2025

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy. February 10, 2025

Multicenter Retrospective Registry Study on BCG Use in Non-Muscle Invasive Bladder Cancer in Latin America: BLATAM (Bladder Cancer in Latin America) Group. February 10, 2025

Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract. February 10, 2025

"Δ" Delta neobladder: a novel stentless simplified totally intracorporeal robotic technique. February 10, 2025

Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study. February 7, 2025

Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer. February 7, 2025

Page 8 of 535